Grant R Zimmermann, PhDDirector of Business Development, Harvard Medical School
Grant joined OTD in 2012. Prior to joining Harvard, Grant was Vice President of Strategic Alliances at Zalicus Inc. partnering an oncology-focused, combination-drug discovery platform with pharma and biotech. Previously, he was head of technology development and inflammation research at CombinatoRx, Inc. advancing multiple candidates through discovery and pre-clinical development, including a phase 2b candidate for rheumatoid arthritis. Grant holds a BS in biochemistry from the University of Illinois at Urbana-Champaign, and a PhD in chemistry from the University of Colorado at Boulder. He was an American Cancer Society postdoctoral fellow at Harvard Medical School.